LARGO, Fla., Feb. 6 /PRNewswire-FirstCall/ -- GeoPharma, Inc. (Nasdaq: GORX) (the "Company") announced today in an effort to communicate its story to as wide of an audience as possible it has placed both of the recent research reports issued about the company on its website at http://www.GeoPharmainc.com under the "Analyst Coverage" tab in the "For Investors" section and that it will be speaking publicly several times in the next few months.
In the most recent research report issued by Andre Garnet of Red Chip, a one year price target of $8 per share was established.
Additionally, GeoPharma has a speaking engagement at the Red Chip Small Cap Investor Conference in Scottsdale, AZ on Thursday, February 7th at 10:10 AM MST.
For those unable to attend in person, the presentation may be viewed online by logging in to the following site: http://www.visualwebcaster.com/event.asp?id=45650.
Speaking about GeoPharma, Red Chip President David Gentry remarked, "GeoPharma is one of the most compelling small cap stories I have seen and is exactly the type of fast growing undervalued situation the retail and institutional clientele that attend our conferences find attractive."
GeoPharma will also be an attending presenter at the Spring EdgeWater Research Partners conference being held at the Grand Hyatt in Denver, Colorado on April 8, 2008. EdgeWater, an Independent research organization and subscription based newsletter just recently issued a research report of its own on GeoPharma, formulating a price target of $7.25 with an 18-24 month time horizon.
Commenting on GeoPharma, EdgeWater Research analyst and publisher Dave
Lavigne stated, "GeoPharma's story is just starting to unfold; we are
pleased to have them join us at the spring conference in April to
communicate their most recent developments."
|SOURCE GeoPharma, Inc.|
Copyright©2008 PR Newswire.
All rights reserved